Insurance by BogdanovaThe Encyclopedia of Insurance and Risk Science

RESEARCH DOSSIER

Market-Consistent Valuation and Insurance Economic Surplus

Abstract. Market-consistent valuation determines the current economic value of insurer assets and obligations by integrating observable market prices, replicating instruments, projected insurance cash flows, and explicit treatment of risks that cannot be completely hedged. Economic surplus is the residual value of assets after the liabilities defined for a specified valuation perimeter and measurement basis. These apparently simple definitions conceal difficult choices about discount curves, financial options, contract boundaries, nonfinancial risk margins, management actions, illiquid markets, credit spreads, and the availability of capital to meet policyholder obligations. This monograph develops an integrated account of those choices, starting with financial economics and extending to the prudential balance sheet, insurance accounting, shareholder embedded value, and insurance capital standards. It conducts documentary comparison of Solvency II, IFRS 17, IFRS 9, IFRS 13, the International Association of Insurance Supervisors' Insurance Capital Standard, U.S. statutory accounting, and the CFO Forum's market-consistent embedded-value principles. An original transparent numerical example distinguishes parallel interest-rate shifts, asset credit-spread changes, equity losses, liability cash-flow shocks, and risk-margin changes. The analysis shows why market-consistent valuations cannot be reduced to uniform discounting and why a change in reported surplus may represent repricing, changed expected claims, a changed risk allowance, or an alteration of the applicable legal measurement basis. The principal scholarly contribution is a source-grounded reconciliation of valuation mechanisms and their economic interpretation, not a new theory or an empirical claim about an unidentified insurance population. Results are conditional on the stipulated asset-liability perimeter, modeled cash flows, calibration date, supervisory rules, and available market evidence.

Keywords: Market-consistent valuation; insurance economic surplus; economic balance sheet; insurance assets; insurance liabilities; best estimate; risk margin; discount curves; Solvency II; IFRS 17; IFRS 9; IFRS 13; Insurance Capital Standard; asset-liability management; embedded value; market risk; interest-rate risk; stochastic valuation; insurance capital; prudential valuation.

Introduction

The economic condition of an insurer is inseparable from the manner in which assets and obligations are valued. An insurer can hold the same contractual portfolio and record different residual equity amounts under a prudential solvency balance sheet, general-purpose financial statements, and an internal economic model. The discrepancy can be economically meaningful: different frameworks recognize different assets, discount obligations differently, treat profits from future services differently, and impose different allowances for uncertain future cash flows. A proper assessment begins by specifying the valuation question and the legal or contractual perimeter to which the answer belongs.

The European Union's Solvency II valuation provisions articulate a market-based approach to assets and liabilities and require technical provisions built from best estimates and risk margins. The IFRS Foundation's IFRS 17 insurance measurement instead serves financial reporting and includes the contractual service margin for the unearned profit of relevant groups. These systems share current estimates and sensitivity to economic conditions, yet their outcomes need not coincide. The EIOPA implementation report specifically records the substantive similarities and differences between their insurance-liability measurements (EIOPA, 2024).

This Research Dossier treats economic surplus as an analytically defined residual, identifies the measurement assumptions needed for that residual to carry information, and traces changes in surplus to their economic sources. Formal derivations and stylized scenarios are reproducible from explicit assumptions. The discussion covers international supervisory approaches while locating each legal statement in its own jurisdiction and effective period. No public release, policyholder-specific assessment, insurer rating, or investment recommendation is made by this archival research manuscript.

Research Object, Questions, and Method

The research object is the valuation of insurer balance-sheet claims in a given currency, at a given date, under market information and a stated liability settlement or transfer basis. The central questions are how asset repricing and insurance liability remeasurement interact; which components of an insurance obligation have market-replicable value; how risk margins affect the residual; when that residual differs from recognized or eligible capital; and how different regulatory regimes translate similar financial economics into different reported quantities.

The method combines four distinct forms of evidence. First, legal and institutional documents establish what a particular framework actually requires. Second, financial economics establishes valuation relationships under explicit assumptions, including state prices, replicating portfolios, and no-arbitrage restrictions. Third, actuarial analysis represents uncertain future benefits, premiums, expenses, claims handling, and policyholder behavior as probability-weighted cash flows. Fourth, an illustrative balance-sheet case provides algebraic reconciliation and scenario sensitivity. Regulatory metrics and aggregate published statistics are used to interpret institutions, not to infer a causal parameter about an individual company.

The work assesses standards as of November 14, 2026. Under Directive (EU) 2025/2, member states are required to transpose the specified revisions by January 29, 2027 and apply them from January 30, 2027; the amending delegated regulation also specifies application from January 30, 2027. Accordingly, this study separates rules applicable in November 2026 from the incoming 2027 architecture (European Parliament and Council, 2025; European Commission, 2026).

Economic Value Concepts

Definitions and the Valuation Perimeter

Let the market-consistent value of recognized assets at date 0 be A, the valuation of insurance cash-flow obligations be L, and other recognized liabilities be O. An economic residual measured on that basis is

Seconomic=A−L−O.S_{\mathrm{economic}} = A - L - O.

The identity is an accounting equation with an explicitly economic interpretation only when A, L, and O are valued coherently and their scope is known. It is not a statement that S is immediately distributable cash, transferable ownership value, eligible own funds, or an amount that could be realized in a disorderly liquidation. A group-level calculation also requires consolidation adjustments, treatment of intra-group reinsurance, and attribution of minority interests. A company may have substantial accounting equity while holding an illiquid or legally restricted asset that cannot support near-term claims.

Market consistency is a requirement on how prices and financial-risk assumptions relate to information in observable markets. At its strongest, it means that cash flows replicable by traded instruments have the value of the replicating portfolio. For nonreplicable risks it requires transparent assumptions about the additional allowance needed, the contractual settlement mechanism, and any applicable regulatory convention. Thus two entities can both apply market-consistent reasoning to traded cash flows while obtaining distinct liability figures because of different nonfinancial-risk adjustments or contract-boundary rules.

IFRS 13 defines fair value with reference to a market-participant exit price, the amount received to sell an asset or paid to transfer a liability in an orderly transaction at the measurement date. Its fair value framework is relevant when another IFRS Standard requires or permits fair-value measurement; it does not automatically replace the specific fulfillment measurement used for insurance contracts in IFRS 17 (IFRS Foundation, 2011). The labels 'fair', 'economic', 'market-consistent', and 'prudential' therefore identify distinct measurement questions that must be resolved before comparing surplus figures.

Financial Economics and Replication

Write D(0,t) for the date-0 price of one unit of default-free currency payable at time t. A deterministic payment C_t with no embedded optionality has a present value C_t D(0,t). With an annually compounded flat rate r, the discount factor is D(0,t) = (1+r)^(-t). This is a price relation, not a forecast of the asset's realized investment return.

For a fully replicable contingent payment X_T, the idealized arbitrage-pricing relationship takes the form

V0(XT)=EQ[D(0,T)XT],V_0(X_T)=E^{Q}[D(0,T)X_T],

when Q is an appropriate pricing measure, the discount process is properly specified, and the integrability and market assumptions of the model hold. In general stochastic-rate models the discount factor is path dependent and belongs inside the expectation. The expression cannot be transported unchanged to a nontraded insurance loss without a justified pricing rule for unhedgeable risks. Black and Scholes' option-pricing analysis supplies a seminal traded-asset example, and Harrison and Pliska's continuous-trading treatment explains the role of equivalent martingale representations and completeness (Black and Scholes, 1973; Harrison and Pliska, 1981).

A replicating portfolio is valuable for insurers because guaranteed rates, investment-linked payments, surrender options, and interest-rate guarantees can have substantial financial-option components. A fixed guarantee in a contract can be economically costly even when current projected cash flows appear inexpensive. Replication calibrates market risk where actively traded instruments provide sufficiently informative prices; it does not eliminate mortality, morbidity, claim severity, policyholder behavior, or operational uncertainty from the insurance obligation.

Incomplete Markets and Nonhedgeable Insurance Risk

Insurance liabilities are typically contingent on events without continuously traded, perfectly replicating assets. Catastrophe outcomes, longevity, judicial developments, latent claims, and behavioral reactions have limited or imperfect hedging instruments. In an incomplete market, absence of arbitrage alone often leaves multiple admissible pricing measures. A risk allowance therefore depends on additional economic preferences, capital constraints, transaction conventions, or the particular requirements of a prudential or accounting framework.

The Föllmer and Sondermann discussion of hedging nonredundant contingent claims illustrates the economic problem of residual risk when trading assets cannot span all future payment states (Föllmer and Sondermann, 1986). In insurance terms, a best estimate may capture the expected settlement amount, while a prudential risk margin or financial-reporting risk adjustment accounts for the compensation associated with specified uncertainty. One should never add these margins mechanically across frameworks: their conceptual bases, risk coverage, calibration, and reporting roles differ.

Market Consistency, Accounting Fair Value, and Economic Capital

An economic balance sheet answers what the modeled net obligations and supporting assets are worth. An economic-capital calculation separately asks how much financial capacity is needed to absorb adverse changes over a defined risk horizon and confidence criterion. The former is a level; the latter is a risk measure on the distribution of changes in the level. One might write C = VaR_alpha(-Delta S) or C = ES_alpha(-Delta S), subject to the chosen horizon, loss convention, conditioning assumptions, and whether valuation changes are evaluated before or after management actions. A positive S does not imply C is sufficient.

Regulatory solvency ratios make this distinction practical. A common simplified ratio of eligible own funds to a prescribed capital requirement contains a numerator filtered by eligibility rules and a denominator defined by a risk-calibration rule. It is generally different from the unfiltered economic surplus S, and different again from accounting equity. The IAIS capital-standard description identifies a globally comparable group-capital measure for internationally active insurance groups, not a universal public measure of every insurer's economic wealth (IAIS, 2024).

Market Valuation of Assets

Instruments, Observable Prices, and Discount Factors

Asset valuation begins by classifying claims according to what they pay and whether price evidence is available. Currency and deposits usually have directly observable nominal values subject to counterparty and legal limitations. Government bonds and corporate bonds have market quotes or model-implied prices from yields and credit spreads. Equities, funds, derivatives, mortgages, loans, real estate, and private placements have increasingly model-dependent valuations as market liquidity and price transparency decline.

For a coupon bond paying c_t each period and principal F at maturity T, the idealized present value is

P0=∑t=1TctD(0,t)+FD(0,T).P_0=\sum_{t=1}^{T}c_t D(0,t)+F D(0,T).

This formula is valid as written for deterministic default-free payments denominated in the relevant currency. A defaultable bond requires a credit-risk model or an observed credit-risk-adjusted market price, and a floating-rate or callable asset requires contingent cash-flow valuation. Substituting a single yield into a complex bond is sometimes a useful summary, but can obscure the term structure, optionality, and liquidity effects relevant to the insurer.

The IFRS 13 market-participant perspective requires valuation assumptions reflecting current market conditions when that Standard governs fair value. A price is ordinarily strongest evidence for the instrument that actually traded; model extrapolations to nontraded or economically dissimilar claims require explicit adjustments. The distinction matters especially when a quoted price reflects a stressed sale, a structural market impairment, or an instrument with contractual restrictions.

Credit, Liquidity, and Market-Price Calibration

A bond's quoted yield can be decomposed schematically into a reference risk-free component, a credit component, compensation for liquidity and other risks, and residual basis differences. This is an explanatory decomposition rather than an exact additive law under every stochastic model. For small yield changes, the first-order bond-price approximation is Delta P approximately -P D_mod Delta y, where D_mod is modified duration. Convexity, issuer default probability, spread migration, callable structure, and currency basis modify actual outcomes.

Insurers often acquire credit-risk-bearing assets because long-duration fixed-income cash flows can support predictable liabilities. The asset's spread is not automatically a risk-free addition that may be applied to every insurance liability. Doing so would convert issuer or liquidity risk into an unearned discount on policyholder obligations. The EU's risk-free curve methodology and EIOPA's published term structures and documentation illustrate how a supervisory rate curve is explicitly constructed, including prescribed mechanisms rather than discretionary use of each insurer's asset yield (European Commission, 2022; EIOPA, 2026).

For a portfolio, market consistency further requires consistency between asset and liability currencies, dates, observable yield curves, inflation indices, derivative conventions, and market states. If an insurer hedges a guarantee with interest-rate swaps, the valuation of the liability option and the hedging instrument should use coherent yield and volatility inputs. A discrepancy would create artificial surplus sensitivity and potentially mislead hedging decisions.

Insurance Balance-Sheet Asset Classifications

The measurement assigned to an economic asset need not match its general-purpose financial statement carrying amount. IFRS 9 assigns financial assets to amortized cost, fair value through other comprehensive income, or fair value through profit or loss according to the business model and contractual-cash-flow conditions described in its financial-instrument classification rules (IFRS Foundation, 2014). A bond carried at amortized cost can have a changing market value even when its accounting carrying value changes more gradually. Consequently, reported accounting equity may react differently from an economic surplus measured on current market prices.

The difference is particularly important in prolonged rate movements. Market prices of long-duration assets fall when applicable discount yields rise; an amortized-cost presentation can defer recognition of some price changes even though the opportunity cost and potential sale value have changed. Conversely, an economic model based only on asset prices can exaggerate a deterioration if the associated liability's market-consistent value falls by an equal or greater amount and the total asset-liability position remains well matched.

Asset Valuation and Capital Availability

The economic value of assets must be distinguished from their availability for policyholder protection. Collateral pledged to derivatives, assets held in ring-fenced funds, encumbered property, legally restricted capital, and intra-group claims can possess financial value while being unusable for specified obligations. Asset transferability, fungibility across legal entities, liquidity under stress, taxation on realization, and the rights of participating policyholders change the economically useful surplus.

U.S. Statutory Accounting Principles explicitly focus on the recognition of assets available to support policyholder obligations and on solvency-oriented financial statements, subject to state prescribed and permitted accounting practices (NAIC, 2026). An asset can be economically valuable yet excluded from the statutory surplus calculation. This observation is more precise than describing one number as the insurer's universally correct capital amount.

Liability Discounting and Risk Adjustments

Best-Estimate Projected Cash Flows

The valuation of insurance obligations begins with a contingent, often path-dependent stream of payments. Denote by C_t the net settlement cash flow at t, with positive values representing a net insurer outflow. It may incorporate benefits, claims, future servicing costs, expenses, and contractually permitted inflows, within the contract boundary required by the applicable framework. A generic best-estimate present value is

BE0=EP[∑t=1TD(0,t)Ct],BE_0 = E^{P}\left[\sum_{t=1}^{T}D(0,t)C_t\right],

for a deterministic reference discount curve and real-world projection measure P, provided the cash-flow distributions and treatment of financial risk are appropriate. This is an illustrative actuarial expression, not the full prescribed formula for any particular regulatory or IFRS category. Where cash flows depend on traded market variables, consistent valuation may instead use a market-calibrated pricing measure, a state-price formulation, or an equivalent cash-flow-and-discount treatment. Financial risks must not be counted twice in both projected cash flows and discount rates.

Under Solvency II, Article 77's best estimate is the probability-weighted average of future cash flows taking account of time value using the relevant risk-free term structure. Forecasts must reflect credible information, realistic assumptions, and all relevant future cash inflows and outflows over the obligations' lifetime. Reinsurance recoverables are calculated separately rather than deducted from the gross best estimate in the statutory calculation (European Parliament and Council, 2009).

A correct expected value requires more than a central forecast. For claims inflation, the mean severity may diverge from an extrapolation of the median. For guarantees, the expected payoff is nonlinear. For longevity risk, improvements in survival may propagate simultaneously across many annuity contracts. For expenses, portfolio run-off can increase unit expenses as fixed costs are allocated across fewer remaining policies. Sensitivity to these mechanisms is a genuine part of liability valuation.

Choice of Discount Curve

A liability discount curve must correspond to the currency, horizon, financial risk, and framework being measured. In a complete market, the curve for a precisely replicated cash flow follows the price of its replicating securities. In a prudential framework the mandated risk-free structure, extrapolation rules, and eligible adjustments govern. In an accounting context the principles of the applicable reporting standard determine discount rates that reflect time value and relevant financial risks not already incorporated in the cash flows.

The EIOPA risk-free term-structure repository publishes monthly technical inputs for Solvency II. Its documentation addresses extrapolation beyond observable market maturities and framework-specific adjustments. A discount rate for a 30-year insurance promise cannot simply be taken from the insurer's recent realized asset income, since doing so ignores both the contractual risk position and the market-implied price of time. The term structure also needs to be evaluated separately from inflation and currency assumptions.

Under IFRS 17, the present-value element of fulfillment cash flows is updated using discount rates consistent with the characteristics of those cash flows, along with distinct rules for presentation of insurance finance income or expense. The IFRS 17 accounting model specifically separates measurement of future cash flows from recognition of unearned profit; it should not be interpreted as direct application of the IFRS 13 exit price to all insurance liabilities (IFRS Foundation, 2017).

Nonfinancial Insurance Risk and Margins

A probability-weighted best estimate expresses a central financial valuation of projected payments. A risk allowance recognizes that carrying, fulfilling, or transferring uncertain obligations can require additional compensation, capital, or expense. Within Solvency II, technical provisions generally equal best estimate plus risk margin. The directive's risk-margin requirement refers to the amount insurance undertakings would be expected to require in order to take over and meet the obligations. The operative implementing rules govern methodology and calibration; a generic cost-of-capital coefficient should never be inserted without specifying the applicable date and legal text.

Within IFRS 17, the risk adjustment concerns compensation the entity requires for bearing uncertainty about amount and timing arising from nonfinancial risk. The contractual service margin then reflects unearned profit for the relevant insurance contract group under that standard. The EIOPA comparative assessment confirms that the underlying purposes, assumptions, risk measures, and treatment of unearned profit differ between IFRS 17 and Solvency II (EIOPA, 2024).

A conceptual reconciliation can be written as L_prudential = BE_prudential + RM_prudential, while L_IFRS17 = FCF_IFRS17 + CSM for the applicable liability group. The terms differ in contract group, cash-flow boundary, discounting, risk adjustment, and presentation. Therefore RM_prudential cannot generally be equated to the IFRS 17 risk adjustment, and CSM cannot be casually inserted into a prudential economic liability as though it were a claim payment to policyholders.

Embedded Options, Guarantees, and Behavior

Life insurers and some nonlife insurers issue contracts with guarantees, options, and actions contingent on financial markets. For example, a minimum maturity guarantee may make the insurer's exposure resemble a portfolio of bonds plus options. The economic cost grows nonlinearly as interest rates fall or market volatility increases. Dynamic lapses, surrender penalties, policyholder elections, and management discretion may change the distributions of future cash flows.

The CFO Forum's MCEV Principles and Guidance explicitly require stochastic consideration of financial options and guarantees for market-consistent embedded value, as well as allowance for frictional costs and residual nonhedgeable risks (CFO Forum, 2016). This illustrates a central limitation of static projected-liability comparisons: two products with similar expected cash flows can have quite different valuations because their asymmetric payoff profiles differ.

A model should treat management actions as feasible, documented, legal, consistent with policyholder responses, and conditional on future circumstances. A hypothetical discretionary bonus cut that is legally unavailable or implausible under observed management practice cannot be assumed to reduce liabilities simply because it improves the projected surplus. For participating contracts, future bonuses and shareholder transfers also have distributional implications: total asset value may be shared between policyholders and shareholders according to contractual and regulatory rules.

Long-Term Contracts, Reinsurance, and Inflation

Insurance liabilities often extend beyond the deepest reliable market maturity. Extrapolation of rates and inflation assumptions can dominate the measured present value of long-duration obligations. Small long-end changes can shift the surplus of a life-annuity insurer even with unchanged expected nominal payments. Large but infrequent claims may depend on catastrophe intensity, claims-cost inflation, judicial developments, and claims-settlement timing.

Reinsurance adds further layers. A gross liability, a reinsurance recoverable asset, collateral, counterparty default exposure, reinstatement premium, basis mismatch, and a contract boundary for reinsurance held must be consistently identified. An insurer's gross risk transfer does not automatically create an equal and risk-free recoverable. Recoverable valuation also depends on its own contractual terms and counterparty. These elements influence both measured economic surplus and future loss distribution.

An actuarial process should reconcile payment timing, data vintages, expense classifications, recoverables, and assumptions. The current ASOP No. 22 asset-adequacy standard emphasizes documentation of data, assumptions, methods, management actions, and asset-liability adequacy for the specified U.S. actuarial opinions; its purpose illustrates why an apparently precise valuation number needs an auditable analytical path (Actuarial Standards Board, 2021).

Economic Surplus Reconciliation

An Economic Balance-Sheet Identity

For an insurer whose insurance liability is represented by a best estimate plus a margin, define

S0=A0−BE0−RM0−O0.S_0=A_0-BE_0-RM_0-O_0.

This formula is the central economic residual for the stated perimeter. It is valid whether S is positive or negative. Different accounting or regulatory rules change the included quantities and therefore the numerical surplus. A coherent reconciliation maintains separate columns for (a) asset price measurement, (b) cash-flow best estimate, (c) nonfinancial and residual margin, (d) other obligations, and (e) regulatory or accounting recognition adjustments.

The change in surplus between two dates can be decomposed, before ownership transactions and perimeter changes, as

ΔS=ΔA−ΔBE−ΔRM−ΔO.\Delta S=\Delta A-\Delta BE-\Delta RM-\Delta O.

This exact decomposition contains no causal interpretation on its own. It becomes an explanatory bridge when the measured changes are independently attributed to interest-rate movements, spread changes, equity returns, revised claims, assumption updates, portfolio flows, capital transfers, or methodological revisions. An adverse movement in one line need not have the same sign as the change in the overall residual.

Regulatory Own Funds and Accounting Equity

Solvency II basic own funds, ancillary own funds, tiering, eligibility, and available capital each have legal definitions and restrictions. A simplified surplus of assets over liabilities is an important starting point, while eligible own funds cannot be asserted equal to that balance without the required adjustments. Prudential valuation and capital eligibility answer different questions: current recognized value on the one hand, and resources that may count toward a prescribed requirement on the other.

IFRS equity reflects IFRS asset measurement, IFRS 17 insurance-contract liabilities or assets, other financial liabilities, and income recognition. The IFRS 9 classifications and IFRS 17 fulfillment and CSM create reporting outcomes that may diverge from economic surplus even for identical underlying contracts. Comparing ratios without reconciling these accounting bases can produce a misleading ranking of insurer resilience.

Market-Consistent Embedded Value

Market-consistent embedded value (MCEV) is a shareholder-oriented valuation methodology for covered business. The CFO Forum's 2016 MCEV principles present MCEV as the sum of free surplus allocated to covered business, required capital, and the value of in-force covered business, with allowance for risk. Future new business is excluded. The value of in-force business reflects projected future profits less relevant option and guarantee values, frictional costs, and residual nonhedgeable-risk costs (CFO Forum, 2016).

MCEV can illuminate shareholder value in long-term insurance operations but is not numerically interchangeable with the Solvency II excess of assets over liabilities. Covered-business boundaries, taxes, management decisions, distribution restrictions, and projected future shareholder earnings all affect the valuation. Likewise, an MCEV increase need not represent improved short-term solvency if the increase depends on remote projections or assumptions that are sensitive to market volatility.

A Worked Numerical Reconciliation

Consider a completely hypothetical insurer with market-valued assets of 1,200 monetary units: 800 in fixed-income securities, 300 in equities, and 100 in cash. For the illustration, assume its only insurance net cash outflow is a deterministic payment of 1,000 at the end of year four; the flat annual risk-free spot rate is 3%; its assumed risk margin is 35; and its other liabilities are 25. The risk margin is stipulated for arithmetic and is neither estimated from a regulator's prescribed formula nor presented as an empirical calibration.

The present value of the payment is

BE0=1,000(1.03)4=888.4870.BE_0=\frac{1{,}000}{(1.03)^4}=888.4870.

The simplified economic surplus is

S0=1,200−888.4870−35−25=251.5130.S_0=1{,}200-888.4870-35-25=251.5130.

The separation of components is essential. The example does not imply that a real insurer's claims are deterministic, or that a liability with a certain payment needs a material nonfinancial risk margin. Instead, it combines a tractable single cash flow with a separately assumed margin to show the structure of reconciliation and margin sensitivity. In a strictly risk-free contract with no residual nonhedgeable risk, an appropriate corresponding margin could be zero; the 35 is a pedagogical overlay representing other portfolio uncertainty omitted from the stylized cash flow.

For transparency the scenario table below holds all unmentioned inputs constant; results reflect isolated shocks rather than a joint probabilistic distribution.

Scenario Explicit shock assumption Approximate economic surplus
Base Assets 1,200; BE 888.487; margin 35; other obligations 25 251.513
Risk-free curve +100 basis points Fixed-income assets lose 32 under assumed modified duration 4; liability discounted at 4% 253.196
Equity market -20% Equities fall 60; liabilities unchanged 191.513
Asset credit spread +150 basis points Fixed-income assets lose 48 with modified duration 4; liability reference curve unchanged 203.513
Additional claims at year four Additional payment 100 at end of year four, discounted at 3%; all else constant 162.664
Risk margin increase Margin rises from 35 to 45 241.513

For the rate scenario, the liability amount is 1,000/(1.04)^4 = 854.8042, while assets are assumed to decline from 1,200 to 1,168. The stressed residual is 1,168 - 854.8042 - 35 - 25 = 253.1958. The rise of approximately 1.683 is the difference between the stipulated bond price loss and the greater absolute reduction in liability present value. Actual fixed-income convexity and liability revaluation would require instrument-level recalculation.

The credit-spread scenario is intentionally asymmetric: the fixed-income holdings lose economic value from their spread widening, while a liability discounted on an unchanged prescribed reference curve does not acquire that same spread. This contrasts with an impermissible shortcut that reduces insurance obligations whenever the insurer buys higher-yielding credit assets. Likewise, the claim-shock case introduces a newly assumed additional expected cash flow rather than repricing the original risk-free liability.

Financial Risk Sensitivity

Interest-Rate and Duration Mismatch

For small parallel yield changes, the local linear sensitivity of surplus can be approximated by

ΔS≈−DAArateΔy+DLLrateΔy,\Delta S \approx -D_A A_{\mathrm{rate}}\Delta y+D_L L_{\mathrm{rate}}\Delta y,

where the duration-weighted asset and liability exposure terms refer only to cash flows repriced by the specified rate shock. This expression is a first-order approximation and assumes the signs and measurement bases have been defined consistently. If asset and liability duration-weighted values are closely matched, a small parallel move creates a smaller immediate surplus effect. Mismatched maturity profiles, optionality, and convexity can produce large effects despite similar average duration.

Immunization must be evaluated against nonparallel shifts, key-rate durations, spread changes, and interest-sensitive policyholder behavior. A life insurer may be broadly hedged against a one-percentage-point parallel shock but vulnerable to steepening of the long end or a decline in rates that raises the value of minimum credited-rate guarantees. For a long-tail nonlife insurer, claims inflation can move with interest rates in economically complex ways. A single duration-gap statistic is a useful diagnostic, not a complete sensitivity estimate.

Credit, Equity, Insurance, and Margin Scenarios

Credit stress should be disaggregated into migration/default losses, spread repricing, liquidity effects, and the effect of reinsurance counterparty deterioration. Equity stress changes assets directly and can also alter guarantee values or future policyholder actions. Insurance stress revises the amount, frequency, severity, timing, or dependence of claims. Margin stress changes the allowance required by a particular measurement basis; it may be correlated with revised future capital requirements and risk perceptions.

In the numerical example, a 20% equity decline destroys 60 units of measured surplus, whereas a stipulated margin increase of 10 destroys 10 units. These results are linear because the inputs are deliberately simplified. With actual embedded financial guarantees, adverse equity movements can simultaneously reduce equity holdings and increase liability option values. A credible combined stress therefore recalculates both sides rather than summing independent shocks without checking nonlinear interaction.

A second critical separation concerns solvency and liquidity. An insurer can have positive market-consistent surplus yet face severe near-term payment pressure if assets cannot be liquidated without discounts, if derivative collateral demands accelerate, or if claims arrive before expected premiums. The economic value of future claims-paying resources and the timing of available cash must both be examined. Supervisory stress testing and internal liquidity management consequently supplement surplus measurement rather than merely restating it.

Nonlinearity, Dependence, and Model Risk

Insurance cash flows depend on hazard, mortality, morbidity, policyholder choices, claims inflation, and management discretion. Financial markets introduce dynamic rates, credit migration, correlated asset losses, and liquidity dislocations. Their dependencies may strengthen in stress conditions. A model calibrated exclusively to ordinary-period correlations can substantially understate the coincidence of asset losses and adverse liability experience.

Prudent modeling uses scenario revaluation and stochastic methods selected for the product and the decision. A validation program should test calibration to traded securities, projection consistency, sensitivity to extrapolation, scenario selection, the quality of insurance experience data, tail dependence, reserve-development uncertainty, and the economic feasibility of management actions. The ASOP No. 22 documentation requirements provide a concrete professional example of documenting the assumptions and scope of asset adequacy analysis in its relevant U.S. setting (Actuarial Standards Board, 2021).

Different model classes are not interchangeable without justification. A market-consistent stochastic option valuation requires market-calibrated dynamics for traded risks. A real-world enterprise capital projection requires empirically credible loss distributions and dependencies. Confusing their probability measures can generate incorrectly priced guarantees or improperly measured economic capital. A practical workflow documents the measure, calibration targets, and purpose of every model run.

Reproducibility and Validation Controls

The numerical results above were checked from the displayed equations and explicit scenario assumptions. The four-year present values are 888.4870479 at 3% and 854.8041910 at 4%. With 32 units of asset loss, the rate stress yields 253.19580897. The extra 100 payable in year four reduces surplus by 88.84870479. Rounding occurs only for publication display.

For a real insurer, reproducibility requires source snapshots for market data, curve construction versions, cash-flow inputs, model code, contract interpretation, and reconciliations to financial ledgers. It also requires independent checks of data lineage, model changes, and the numerical effect of judgmental assumptions. An observed increase in surplus after a model revision should be separated from genuine earned profitability, market repricing, capital injection, new underwriting, or structural changes in insurance liabilities.

Cross-Framework Comparison

Solvency II and Its 2027 Amendments

Solvency II valuation combines market-oriented asset and liability values with specifically defined technical provisions, reinsurance recoverables, own funds, and capital requirements. Articles 75 and 77 of the original Solvency II directive provide the primary valuation foundations; the applicable consolidated and delegated measures determine detailed methodologies (European Parliament and Council, 2009). Assets and liabilities are valued within a prudential framework designed to support policyholder protection, and insurance technical provisions generally comprise a best estimate and risk margin.

Regulatory change is material to comparative research. The Solvency II amending directive was enacted before this manuscript's cutoff, but its substantive transposition/application schedule extends to January 2027. The 2026 delegated amendment expressly applies from January 30, 2027 (European Parliament and Council, 2025; European Commission, 2026). This document does not present the future rules as already applied in November 2026. Quantitative results under post-January 2027 calibration require separate future-effective documentation and applicable technical inputs.

IFRS 17, IFRS 9, and IFRS 13

IFRS 17 establishes current fulfillment measurement for insurance groups, a risk adjustment for nonfinancial risk, and a contractual service margin representing unearned profit where applicable. Its insurance-contract standard became effective for annual reporting periods beginning on or after January 1, 2023, subject to its specified transition and early-adoption provisions (IFRS Foundation, 2017).

IFRS 9 governs classification and measurement of many insurer financial assets; its financial-asset categories depend on business-model and contractual-cash-flow characteristics. IFRS 13 describes the market-participant exit-price concept wherever an applicable IFRS Standard requires or permits fair value (IFRS Foundation, 2014; 2011). These standards interact, yet they cannot be collapsed into a single enterprise market-consistent surplus number. In particular, the reporting function of CSM differs from a solvency risk margin or shareholder value allowance.

EIOPA's 2024 IFRS 17 review is relevant empirical institutional evidence: it documents both valuation synergies and substantive measurement divergence in EU implementation. It should not be overread as evidence that every insurer or product experiences the same balance-sheet difference, or that different reported liability totals can be reconciled by a single universal percentage.

IAIS Insurance Capital Standard

The IAIS adopted the Insurance Capital Standard in 2024 as a group capital standard for internationally active insurance groups. Its ICS institutional description identifies its role as the quantitative component of ComFrame (IAIS, 2024). The ICS online technical text sets out market-adjusted valuation and a margin over current estimate (MOCE), together with detailed eligibility and capital calculations. The existence of a margin over current estimate does not make the ICS measure identical to Solvency II's risk margin or IFRS 17's risk adjustment.

The comparison is analytical: both frameworks seek informative group solvency valuations, but their definitions, calibration, legal adoption, and reporting scope require direct reading before numeric comparison. One should identify exactly which parts of the ICS are being implemented in a jurisdiction and distinguish the standard adopted at the IAIS level from domestic supervisory application. This prevents inappropriate international rankings based solely on similar terminology.

United States Statutory Accounting

U.S. statutory accounting is defined in state-law contexts and NAIC guidance. The NAIC's statutory-accounting overview explains its solvency orientation, recognition criteria, and the role of state prescribed and permitted practices (NAIC, 2026). This basis differs from an unrestricted economic market-value balance sheet. The legal and accounting treatment of an instrument can also differ from the classification used in economic valuation.

The NAIC's surplus-note explanation offers a concrete illustration: qualifying insurer-issued subordinated surplus notes are treated as surplus under statutory accounting but as liabilities under U.S. GAAP, subject to applicable terms and approvals (NAIC, 2025). The difference does not extinguish the underlying contractual obligation; it changes the recognized capital classification and therefore the meaning of a reported surplus total. State-specific rules must be checked before applying the principle to a particular company.

Supervisory Data and Economic Interpretation

Aggregate indicators provide context for balance-sheet interpretation but are not substitutable for economic valuation of an individual insurer. The EIOPA October 2026 risk dashboard reports Q2 2026 median solvency ratios of 217.6% for insurance groups, 221.4% for nonlife insurers, and approximately 247% for life insurers, according to its stated populations and definitions (EIOPA, 2026). These are regulatory ratios, not direct measures of distributable economic surplus or insolvency probabilities.

EIOPA's insurance statistics portal provides aggregate balance-sheet and own-funds series and states reporting frequencies and whether extracts are provisional. The current source page identifies 2026 Q2 solo quarterly data and 2026 Q1 group quarterly data as its latest updates in those respective categories as of October 12, 2026 (EIOPA, 2026). A national comparison requires like-for-like scope, regulatory reporting templates, currency, consolidation, and capital-eligibility treatment; raw nominal surplus magnitudes have little international interpretability.

Governance, Disclosure, and Research Limits

A defensible insurer valuation discloses the effective date, framework, consolidation perimeter, currency, principal asset valuation approaches, liabilities and contract boundaries, discount curves, risk and uncertainty margins, optionality, reinsurance, and the material sensitivities that influence the residual. It also documents how unrestricted economic surplus differs from eligible capital and financial-reporting equity. Results should be traced to the applicable standards rather than to similarity of words across institutional frameworks.

The present research synthesizes a selected set of verified primary sources and foundational financial-economic publications. It does not independently replicate regulatory industry datasets, calibrate a full market stochastic model from licensed quotations, obtain confidential insurer cash flows, or measure a jurisdiction-specific institution's actual solvency. The numerical portfolio is explicitly synthetic. A complete enterprise valuation would require data access, stochastic model calibration, legal contract mapping, independent actuarial peer review where mandated, and separate approval under the actual governing jurisdiction. These limitations constrain empirical inference but do not prevent verification of the conceptual or algebraic claims established here.

Conclusion

Market-consistent valuation connects insurer financial condition to observable market prices, time-valued future cash flows, explicit risk allowances, and the financial constraints created by contingent insurance promises. The economic surplus measured under a specified perimeter is the difference between asset value and all modeled liabilities, but its meaning depends on discounting, option value, nonfinancial uncertainty, asset transferability, and the rules governing the balance-sheet measurement.

The analysis establishes four results. First, a revaluation of economic surplus has to reconcile changes in asset prices with changes in liability present values, because considering either side independently can reverse the interpretation of interest-rate movements. Second, market consistency is strongest for replicable financial cash flows; insurance-specific residual risk requires documented treatment beyond no-arbitrage valuation. Third, Solvency II own funds, IFRS equity, IAIS capital resources, U.S. statutory surplus, and MCEV represent related but differently defined valuations or capital concepts, and require adjustments before comparison. Fourth, stress analysis becomes meaningful when the assumptions and risk channels are explicit: the synthetic balance sheet shows positive surplus response to a stipulated parallel rate rise alongside substantial vulnerability to equity losses, widening asset credit spreads, additional future claims, or a higher risk margin.

The original contribution of this Research Dossier is its integrated source-specific reconciliation, explicit analytical distinctions, and reproducible sensitivity example. It introduces no new actuarial theory, valuation doctrine, causal estimate, or historical claim of scientific priority. The resulting scholarly conclusion is operational: every insurer economic-surplus statement should identify its measurement basis, economically relevant assumptions, residual-risk treatment, and sensitivity to joint asset-liability changes before being used to interpret resilience or shareholder value.

References